Thalia Psychotherapy
PrivateLast Round
Series A
Oct 20, 2025
Company Overview
Thalia Psychotherapy operates in Healthcare & Life Sciences and is based in Nairobi. Its latest recorded funding round was a Series A round in October 2025.
Thalia Psychotherapy is a healthtech company that provides mental health infrastructure and integrated care services across Africa.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thalia Psychotherapy Comparables
Compare Thalia Psychotherapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wazi | 78% | |
| AYA-Innovation | 76% | |
| Shamiri Institute | 62% |
For institutional investors. Book with your work email.
Thalia Psychotherapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 20, 2025 | ||||
| Strategic | Aug 1, 2025 | ||||
| Pre Seed | Oct 31, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Thalia Psychotherapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT Solve | Pre Seed |
| HealthTech Hub Africa | Pre Seed |
| Villgro Africa | Pre Seed |
| United Nations Health Innovation Exchange | Strategic |
| Bill & Melinda Gates Foundation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2025
Completed a Series A funding round.
- Aug 1, 2025
United Nations Health Innovation Exchange participated in the round.
For institutional investors. Book with your work email.
Thalia Psychotherapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Thalia Psychotherapy's valuation, stock price, and market status.
Is Thalia Psychotherapy a public or private company?
Thalia Psychotherapy is a private company.
What is the current stock price of Thalia Psychotherapy?
Thalia Psychotherapy is a private company, so its shares have no public market price. Caplight tracks Thalia Psychotherapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Thalia Psychotherapy worth (valuation)?
Valuation information for Thalia Psychotherapy is not publicly available.
Can I buy Thalia Psychotherapy stock?
Thalia Psychotherapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Thalia Psychotherapy's last funding round?
Thalia Psychotherapy's most recent funding round was Series A on October 20, 2025.
Who are the main investors in Thalia Psychotherapy?
Key investors in Thalia Psychotherapy include MIT Solve, HealthTech Hub Africa, Villgro Africa, United Nations Health Innovation Exchange, Bill & Melinda Gates Foundation.
Will Thalia Psychotherapy IPO soon?
No public IPO plans have been announced for Thalia Psychotherapy.
How can I track Thalia Psychotherapy secondary market activity?
Caplight tracks bids, offers, and trades in Thalia Psychotherapy's shares on secondary markets.